Industry · July 18, 2026

Blood Clots After Plastic Surgery: The Risk That Belongs in Every Consult

Most patients preparing for a cosmetic procedure worry about the scar, the anesthesia, or the result. Very few walk into a consultation worried about a blood clot, and yet venous thromboembolism is one of the few complications of elective aesthetic surgery that can kill an otherwise healthy person. A clot that forms in a deep leg vein and travels to the lungs is the reason surgeons put compression sleeves on your calves, get you walking within hours, and ask about your birth control before they ask about your goals. Here is what the evidence actually says about blood clots after plastic surgery, how surgeons score your personal risk, and the questions that separate a practice that takes this seriously from one that treats it as paperwork.

By The Editorial Desk

8 min read

Editorial photograph

Blood clots occupy a peculiar place in the risk conversation around cosmetic surgery: they are among the most serious things that can go wrong and among the least discussed at the consultation. A patient will spend an hour interrogating the shape of a nose or the projection of an implant and not a single minute on venous thromboembolism, the clinical term for a clot that forms in a deep vein, usually in the leg, and the far more dangerous event that follows when a piece of it breaks loose and lodges in the lungs. That second event, a pulmonary embolism, is the reason this topic matters. Most surgical complications are recoverable. A large pulmonary embolism in an otherwise healthy person having an elective operation is the rare one that is not, and it is precisely because these procedures are elective that the risk deserves the attention patients almost never give it. The good news is that the risk is largely predictable and substantially preventable. The catch is that prevention only happens when the surgeon takes it seriously and the patient understands why they are being asked to wear compression sleeves and get out of bed sooner than they would like.

Why blood clots are the complication that gets underweighted

The short answer: a deep vein clot can form silently during a long operation and become a pulmonary embolism days later, which makes it the rare cosmetic-surgery complication that is genuinely life-threatening rather than merely disappointing.

The mechanics are worth understanding because they explain every precaution that follows. Clots form when blood pools and stagnates, when the vessel wall is irritated, and when the blood itself is prone to clotting, a trio clinicians have described for over a century. Surgery hits all three. A patient lies still under general anesthesia for hours, so blood pools in the legs. The tissue trauma of the operation tips the body toward clotting as part of its healing response. Recovery then adds more immobility. A clot can form in a calf vein without a single symptom, and the first sign that anything is wrong may be sudden shortness of breath or chest pain after the patient is already home, when a fragment has traveled to the lung. This is why the danger is easy to underweight. It is invisible on the table, it can announce itself days later, and it does not fit the mental model of a surgical risk as something that happens during the operation. Body-contouring procedures, particularly abdominoplasty and combined operations that keep a patient under anesthesia for many hours, carry some of the highest rates in aesthetic surgery, and pulmonary embolism is consistently cited as a leading cause of death in abdominoplasty specifically.

How surgeons actually score your risk

The short answer: most careful practices use the Caprini Risk Assessment Model, a points-based tool that turns your age, procedure, and history into a risk tier that dictates what prevention you receive.

Blood clot prevention is not one-size-fits-all, and the better practices do not treat it that way. The most widely used tool in plastic surgery is the Caprini Risk Assessment Model, which assigns points for risk factors and sorts patients into tiers that guide how aggressive the prevention should be. Age adds points. So does obesity, a personal or family history of clots, cancer, certain inherited clotting disorders, the length and type of the operation, and estrogen exposure from combined oral contraceptives or hormone therapy. A young, healthy patient having a short procedure lands in a low tier and may need nothing more than compression and early walking. A patient in a higher tier, an older patient, a longer combined case, someone with a prior clot, is a candidate for pharmacologic prevention, meaning a blood-thinning injection such as low-molecular-weight heparin given around the time of surgery. The specific point that patients should take from this is that a real risk assessment produces a specific plan. If a surgeon can tell you which tier you fall into and what that means for your compression, your medication, and how soon you will be up and walking, you are in a practice that has thought about this. If the subject never comes up, that is the finding.

What actually lowers the risk

The short answer: the prevention that works is unglamorous and mechanical: compression on the legs during surgery, getting the patient walking within hours, adequate hydration, and blood-thinning medication for those whose risk tier warrants it.

The interventions that move the needle are not exotic. During the operation, sequential compression devices, the inflating sleeves that squeeze the calves in a rhythm, keep blood moving in the legs and are close to a universal standard of care for anything beyond the briefest procedure. After surgery, early ambulation is the single most emphasized instruction in the guidance: getting a patient up and walking within hours, not days, because immobility is the enemy. Hydration matters because dehydrated blood clots more readily. For patients whose Caprini tier calls for it, chemoprophylaxis, a short course of an injectable anticoagulant, adds a layer of protection that mechanical measures alone cannot provide, and the decision to use it is a genuine judgment call because thinning the blood also raises the risk of bleeding into the fresh surgical site. That tension, clot prevention on one side and bleeding risk on the other, is exactly the kind of trade-off a good surgeon weighs out loud. The through-line is that none of this is high technology. It is attention, and attention is the variable that differs most between practices.

"

A deep vein clot forms in silence and can announce itself days later as a pulmonary embolism, after the patient is already home. It is the rare cosmetic-surgery complication that is genuinely life-threatening rather than merely disappointing.

"

The choices that quietly raise the risk

The short answer: long combined procedures, estrogen-containing birth control, a personal or family history of clots, and the long flight home from surgery abroad all push a patient into higher risk, and each is a decision that can be managed if it is known in advance.

Several of the biggest risk multipliers are things a patient controls or discloses, which is why the pre-operative conversation matters so much. Combining multiple procedures into one long operation to save on cost and recovery is a common request, but every added hour under anesthesia adds risk, and the surgeon's willingness to stage a very long case rather than do everything at once can be a safety decision rather than a scheduling one. Estrogen-containing oral contraceptives and hormone replacement therapy raise clotting risk, which is why surgeons frequently ask patients to stop combined hormonal contraception several weeks before a major procedure and use another method in the interim. A personal or family history of clots is one of the highest-weighted factors in any risk model and needs to be disclosed even if it happened years ago. And the specific trap of cosmetic surgery tourism deserves a mention: a long-haul flight in the days after body-contouring surgery stacks immobility, dehydration, and a fresh surgical clotting response on top of one another, which is a documented recipe for a clot and one reason the honest cost of an operation abroad is not captured in the quoted price.

What patients get wrong, and what to ask

The short answer: patients underweight the risk because it is invisible and rare, over-disclose their goals while under-disclosing their medical history, and treat compression and early walking as annoyances rather than the specific interventions keeping them safe.

The most common patient error is not a dramatic one. It is a quiet failure to connect the boring instructions to the serious risk. The compression sleeves feel like fussy hospital equipment. The nurse insisting you walk to the bathroom on the evening of surgery feels premature. The instruction to stop your birth control weeks ahead feels like an inconvenience unrelated to a facelift or a tummy tuck. In fact each of these is a targeted defense against a clot, and understanding that turns compliance from a chore into self-interest. The second error is disclosure. Patients volunteer every detail of what they want changed and skim past the medical history that actually drives their risk: the aunt who had a clot, the birth control pill they forgot counts as a medication, the previous episode of leg swelling that was never fully worked up. The questions worth asking are direct. What is my clot risk for this procedure, and how did you assess it? Do I need blood-thinning medication or just compression? How soon will I be walking? And should I stop my birth control before surgery? A practice that answers all four without hesitation has already done the thinking. One that treats the questions as unusual has told you something too.

The honest summary

Blood clots are the complication most worth understanding precisely because they are the one patients think about least. Venous thromboembolism is uncommon in elective cosmetic surgery, but when a deep vein clot becomes a pulmonary embolism it is the rare event that can turn an elective operation into a fatal one, and that asymmetry is the whole argument for taking it seriously. The reassuring part is that the risk is both predictable and largely preventable. A structured assessment, most often the Caprini model, sorts patients into risk tiers; mechanical prevention with compression and early walking protects nearly everyone; blood-thinning medication adds protection for those whose risk warrants the trade-off against bleeding; and the biggest multipliers, long combined procedures, estrogen-containing contraception, a clotting history, and the long flight home from surgery abroad, are all knowable in advance and manageable when they are.

The single habit that matters most is disclosure paired with the right questions. Tell the surgeon your full history, including the birth control pill and the relative who had a clot, and ask directly how your clot risk was assessed and what the plan is to lower it. The compression sleeves and the insistence on walking are not bureaucratic rituals. They are the specific, unglamorous interventions that keep a rare risk rare. The practices that take blood clots seriously will tell you exactly how they do it. The ones that wave the question away have already answered a different one.

Related reading: Plastic Surgery Tourism: The Cost That Is Not in the Quote and Why Anesthesia Choice Is Part of the Operative Plan.